Tuesday, January 10, 2012

Actavis Will Pay $118.6 Million to End Drug-Pricing Claims

From Bloomberg:
Units of Actavis Group Hf agreed to pay $118.6 million to resolve claims that they caused the U.S. and four state governments to overpay for drugs.  The settlement, filed Dec. 29 in federal court in Boston, followed an $84 million accord announced a day earlier in a lawsuit by the state of Texas, bringing the total to $202.6 million.  In February, a state court jury in Austin ordered units of the Iceland-based company to pay $170 million for inflating billings to the Texas Medicaid program.
From the Texas Attorney General:
Texas Attorney General Greg Abbott secured an $84 million agreement with pharmaceutical manufacturer Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC.  The agreement resolves the State’s civil Medicaid fraud enforcement action against Actavis, which was charged with defrauding the taxpayers and improperly reporting drug prices to the Texas Medicaid program.  Under the settlement agreement, the Attorney General’s Office recovered $29.23 million for the State’s general revenue fund.

No comments:

Post a Comment